Immuron Ltd ADR (IMRN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.06M
Last updated: Nov 17, 2026 at 11:04 AM ET
Earnings
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 17.1% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 43.4, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about IMRN
News
IMRN Valuation
- P/B
- 1.0x
IMRN Profitability: Margins, ROIC and FCF
Immuron Ltd ADR (IMRN) has a gross margin of 64.3%, an operating margin of -46.2% and a net margin of -47.7%.
- Gross margin
- 64.3%
- Operating margin
- -46.2%
- Net margin
- -47.7%
- ROE
- -38.3%
Immuron Ltd ADR Competitors
The companies most similar to Immuron Ltd ADR (IMRN) include Imunon, Moleculin Biotech and Theriva Biologics.
Sector: Healthcare
IMRN Bull Case vs Bear Case
Bear case
- IMRN has a -47.7% net profit margin.
Updated Aug 30, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About IMRN
Does IMRN pay dividends?
Immuron Ltd ADR (IMRN) does not currently pay a regular dividend.
What is IMRN's market cap?
Immuron Ltd ADR (IMRN) has a market capitalization of $7.06M with a current stock price of $0.90.
IMRN pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.